Prime Minister Keir Starmer’s recent plan to revitalize the NHS highlights critical needs: bringing care closer to communities, bridging the digital divide between hospitals, and reducing waiting times. These goals underscore the growing importance of data-driven medicine in shaping the future of healthcare. As the NHS navigates the challenges of an ageing population and increasing demand, harnessing the power of data is no longer a luxury, but a necessity.
International collaboration and broad access to computational resources will be key to unlocking the benefits AI promises to deliver across society and the economy. 2025 saw the UK government expand its involvement in the European High-Performance Computing (EuroHPC) Joint Undertaking by committing £7.8 million to fund UK researchers and businesses’ participation in EuroHPC research.
Access to data is a double-edged sword
The exponential growth in patient data volume and complexity presents both a challenge and an opportunity. This data deluge holds the key to unlocking personalized and effective treatments, yet many clinicians lack the necessary tools and resources to effectively analyze and interpret it. This can lead to a sense of being overwhelmed, hindering rather than helping patient care.
Clinicians need access to advanced analytics platforms that can securely connect and analyze diverse datasets, including genomic information, to extract actionable insights. These platforms can empower healthcare professionals with the knowledge needed to make informed decisions, leading to more personalized and effective care. AI-powered solutions, for instance, can analyze complex genomic data, identifying patterns and insights that would be impossible for humans to detect unaided, enabling faster diagnoses and more targeted treatment plans.
Bringing care closer to the patient through decentralized testing
Traditionally, DNA samples had to be sent to external laboratories for analysis, leading to longer turnaround times and higher costs. With decentralized testing, hospitals and labs can perform genomic testing within the walls of their own institution. This approach not only reduces diagnostic backlogs but also empowers local healthcare providers with cutting-edge tools.
One example of decentralized testing is the UK’s national genomic testing service which consists of seven Genomic Laboratory Hubs (GLHs). Faster insights enable earlier interventions and more targeted treatment strategies, ultimately improving patient outcomes and reducing anxiety for those awaiting diagnosis. Further to this, decentralized platforms can facilitate secure data sharing and collaboration among healthcare professionals. This model ensures that everyone, including those in underserved and remote communities, benefits from the latest advancements in biomarker-driven treatment, fostering a more connected and efficient healthcare ecosystem.
Paving the way for a data-driven NHS
NHS institutions are already pioneering the integrating of data-driven insights into clinical practice. The Royal Marsden, for example, launched the LIBRA study to develop an AI algorithm that can help doctors diagnose lung cancer earlier, while the South West Genomic Laboratory Hub at North Bristol NHS Trust introduced a cutting-edge genetic sequencing to expedite diagnostics. Having access to technologies that can analyze large volumes of data and draw tangible insights empowers clinicians to make the right treatment decisions for their patients.
Investing in accessible and robust data analysis platforms is crucial for realizing the full potential of precision medicine. These platforms should prioritize data security and patient privacy while providing clinicians with user-friendly interfaces and powerful analytical tools. Cloud-based solutions can also offer scalability, flexibility, and cost-effectiveness, enabling the NHS to adapt to evolving needs and maximize its resources.
To fully leverage the potential of data-driven medicine, interoperability and standardization are essential. Data from various sources, including electronic health records, genomic sequencing platforms, and wearable devices, must be seamlessly integrated and analyzed. Standardized data formats and protocols can facilitate data sharing and collaboration, enabling researchers and clinicians to access and analyze data from different institutions and regions. This collaborative approach can accelerate the development of new diagnostic tools and treatments, ultimately benefiting patients across the NHS.
However, as the use of patient data expands, addressing ethical considerations is paramount. Robust data governance frameworks are needed to ensure patient privacy, data security, and responsible use of AI. Transparency and patient consent are crucial for building trust and ensuring that data-driven medicine is used ethically and responsibly. The NHS must prioritize patient well-being and empower individuals with control over their data, fostering a culture of trust and collaboration.
The future of healthcare: a data-driven vision
Data-driven medicine holds immense promise for transforming the NHS and improving patient care. By investing in the right technologies, fostering collaboration, and addressing ethical considerations, the NHS can unlock the full potential of data to create a more equitable, efficient, and patient-centered healthcare system.
This data-driven approach can empower clinicians, accelerate research, and ultimately, improve the lives of patients across the UK. The future of healthcare is data-driven, and the NHS is poised to lead the way in this transformative journey.
We’ve featured the best telemedicine software.
This article was produced as part of TechRadarPro’s Expert Insights channel where we feature the best and brightest minds in the technology industry today. The views expressed here are those of the author and are not necessarily those of TechRadarPro or Future plc. If you are interested in contributing find out more here: https://www.techradar.com/news/submit-your-story-to-techradar-pro